Artelo Biosciences Inc (ARTL)

NASDAQ HEALTHCARE
$3.41 -4.48% RSI 37 Neutral Add Alert

Moving Averages

SMA 200
$14.46
Price below

Company Profile

Artelo Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. The company is headquartered in La Jolla, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$4.86M
P/E Ratio
None
EPS
$-37.56
Beta
0.409
Dividend Yield
0.00%
52-Week High
$85.8
52-Week Low
$2.955

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0

Data last updated: April 11, 2026 at 7:39 AM EDT

Track ARTL for free

Get e-mail RSI alerts when Artelo Biosciences Inc enters oversold or overbought territory. Free forever.

Add Alert